Study of the quality of life indicators in dependence on neuropsychological changes in patients with miasthenia

Authors

  • Oleksandr Kalbus State Institution “Dnipropetrovsk Medical Academy of the Ministry of Health of Ukraine” Volodymyra Vernadskoho str., 9, Dnipro, Ukraine, 49044, Ukraine https://orcid.org/0000-0003-0796-4825

DOI:

https://doi.org/10.15587/2519-4798.2018.132662

Keywords:

myasthenia, anxiety, depression, quality of life, ophthalmic form, generalized form

Abstract

Aim of the research: to study of the quality of life in adults with myasthenia, depending on the clinical form of the disease and the neuropsychological status of patients.

Materials and methods. An in-depth clinical and neurological examination was carried out, incl. with the definition of myasthenia class by MGFA, neuropsychological (assessment on the scale of Beck depression and determination of anxiety level on the Spielberg-Khanin scale) examination of 96 adult patients (56 women and 40 men) with myasthenia (71 with generalized, 25 with ophthalmic form, respectively).

Results. In assessing the MGQoL-15 scale, the average quality of life measures were 10.3 ± 9.4 points (ranging from 0 to 31).

When assessing situational anxiety on the Spielberg-Khanin scale, a moderate level of anxiety was detected in 44 patients, a high one in 24 patients, while a low level of anxiety was observed in 28 patients.

When comparing the quality of life in patients with myasthenia according to the MGQoL-15 scale and the level of situational anxiety by the Spielberg-Khanin scale, a reliable (albeit insignificant) negative effect of increased anxiety on the quality of life was established (r = -0.24, p = 0.01 ).

Depressive manifestations in the form of mild (32 people) and moderate (34 people) depression were found in 66 patients, the average value on the Beck scale was 12.9 ± 3.5 points.

When comparing the quality of life indicators in patients with myasthenia according to the MGQoL-15 scale and the indicators on the Beck depression scale, a reliable relationship was established between these indicators (r = 0.49, p<0.001).

Conclusions. The indicators of the quality of life of myasthenia patients depend on the severity of the disease. The quality of life is affected by the level of depression and situational anxiety. The highest quality of life is observed in patients with ophthalmic form of myasthenia. The incidence of anxious and depressive disorders in patients with myasthenia increases with the experience of the disease. Disturbing and depressive manifestations are more pronounced in patients with generalized myasthenia compared with patients with an ophthalmic form

Author Biography

Oleksandr Kalbus, State Institution “Dnipropetrovsk Medical Academy of the Ministry of Health of Ukraine” Volodymyra Vernadskoho str., 9, Dnipro, Ukraine, 49044

PhD, Assistant

Department of Neurology and Ophthalmology

References

  1. Kulikova, S. L. (2014). Antitela k atsetilholinovyim retseptoram v diagnostike razlichnyih form miastenii. Nevrologiya i neyrohirurgiya Vostochnaya Evropa, 1 (21), 73–82.
  2. Skeie, G. O., Apostolski, S., Evoli, A., Gilhus, N. E., Illa, I., Harms, L. et. al. (2010). Guidelines for treatment of autoimmune neuromuscular transmission disorders. European Journal of Neurology, 17 (7), 893–902. doi: 10.1111/j.1468-1331.2010.03019.x
  3. Shkolnik, V. M., Kalbus, A. I., Baranenko, A. N., Pogorelov, A. V. (2014). Miasteniya: sovremennyie podhodyi k diagnostike i lecheniyu. Ukrainskyi nevrolohichnyi zhurnal, 2, 12–17.
  4. Shkolnik, V. M., Kalbus, A. I., Shulga, O. D. (2010). Miasteniya: chto nam izvestno segodnya? Zdorovia Ukrainy (nevrolohiia, psykhiatriia, psykhoterapiya), 3 (14), 10–11.
  5. Shulga, O. D., Kalbus, A. I., Shulga, L. A. (2010). Miasteniya. Neyron Revyu, 2, 13–20.
  6. Kulaksizoglu, I. B. (2007). Mood and Anxiety Disorders in Patients with Myasthenia Gravis. CNS Drugs, 21 (6), 473–481. doi: 10.2165/00023210-200721060-00004
  7. Aysal, F., Karamustafalioglu, O., Ozcelik, B. et. al. (2013). The relationship of symptoms of anxiety and depression with disease severity and treatment modality in myasthenia gravis: a cross-sectional study. Archives of Neuropsychiatry, 50 (4), 295–300. doi: 10.4274/npa.y5611
  8. Uyaroglu, F. G., Bilgin, S., Keles, E. H., Zorlu, Y. (2016). Anxiety And Depression Symptoms In Patients With Generalized Myasthenia Gravis. The Journal of Tepecik Education and Research Hospital, 26 (2), 97–103. doi: 10.5222/terh.2016.097
  9. Suzuki, Y., Utsugisawa, K., Suzuki, S., Nagane, Y., Masuda, M., Kabasawa, C. et. al. (2011). Factors associated with depressive state in patients with myasthenia gravis: a multicentre cross-sectional study. BMJ Open, 1 (2), e000313. doi: 10.1136/bmjopen-2011-000313
  10. Blum, S., Lee, D., Gillis, D., McEniery, D. F., Reddel, S., McCombe, P. (2015). Clinical features and impact of myasthenia gravis disease in Australian patients. Journal of Clinical Neuroscience, 22 (7), 1164–1169. doi: 10.1016/j.jocn.2015.01.022
  11. Kulkantrakorn, K., Sawanyawisuth, K., Tiamkao, S. (2010). Factors correlating quality of life in patients with myasthenia gravis. Neurological Sciences, 31 (5), 571–573. doi: 10.1007/s10072-010-0285-6
  12. Padua, L., Evoli, A., Aprile, I., Caliandro, P., Mazza, S., Padua, R., Tonali, P. (2001). Health-related quality of life in patients with myasthenia gravis and the relationship between patient-oriented assessment and conventional measurements. Neurological Sciences, 22 (5), 363–369. doi: 10.1007/s100720100066
  13. Oliveira, E. F., Nacif, S. R., Urbano, J. J., Silva, A. S., Oliveira, C. S., Perez, E. A. et. al. (2017). Sleep, lung function, and quality of life in patients with myasthenia gravis: A cross-sectional study. Neuromuscular Disorders, 27 (2), 120–127. doi: 10.1016/j.nmd.2016.11.015
  14. Yang, Y., Zhang, M., Guo, J., Ma, S., Fan, L., Wang, X. et. al. (2015). Quality of life in 188 patients with myasthenia gravis in China. International Journal of Neuroscience, 126 (5), 455–462. doi: 10.3109/00207454.2015.1038712

Downloads

Published

2018-05-31

How to Cite

Kalbus, O. (2018). Study of the quality of life indicators in dependence on neuropsychological changes in patients with miasthenia. ScienceRise: Medical Science, (4 (24), 28–31. https://doi.org/10.15587/2519-4798.2018.132662

Issue

No. 4 (24) (2018)

Section

Medical Science

License

Copyright (c) 2018 Oleksandr Kalbus

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Our journal abides by the Creative Commons CC BY copyright rights and permissions for open access journals.

Authors, who are published in this journal, agree to the following conditions:

1. The authors reserve the right to authorship of the work and pass the first publication right of this work to the journal under the terms of a Creative Commons CC BY, which allows others to freely distribute the published research with the obligatory reference to the authors of the original work and the first publication of the work in this journal.

 2. The authors have the right to conclude separate supplement agreements that relate to non-exclusive work distribution in the form in which it has been published by the journal (for example, to upload the work to the online storage of the journal or publish it as part of a monograph), provided that the reference to the first publication of the work in this journal is included.